16 Results for "

α3β2

" in MedChemExpress (MCE) Product Catalog:
Products (16)

16 Results for "α3β2" in MCE Product Catalog:

17
17 Publications Verification
Cat. No.: HY-A0106
CAS No.: 14769-73-4
Synonyms: (-)-Tetramisole
Target:  

nAChR Parasite

Levamisole ((-)-Levamisole), an anthelmintic agent with immunomodulatory properties. Levamisole acts as a positive allosteric modulator (PAM) for the α3β2 (EC50=300 μM) and α3β4 (EC50=100 μM) subtype of nAChRs. Orally active .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-110121A
CAS No.: 216853-59-7
Purity:  99.78%
Target:  

nAChR

Research Areas:  

Neurological Disease

NS3861 is an agonist of nicotinic acetylcholine receptors (nAChRs) and binds with high affinity to heteromeric α3β4 nAChR. The binding Ki values of 0.62, 25, 7.8, 55 nM for α3β4, α3β2, α4β4, α4β2, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-110121
CAS No.: 216853-60-0
Purity:  99.71%
Target:  

nAChR

Research Areas:  

Neurological Disease

NS3861 fumarate is an agonist of nicotinic acetylcholine receptors (nAChRs) and binds with high affinity to heteromeric α3β4 nAChR. The binding Ki values of 0.62, 25, 7.8, 55 nM for α3β4, α3β2, α4β4, α4β2, respectively .
loading...
    loading...
Cat. No.: HY-160959
CAS No.: 946074-35-7
Target:  

nAChR

Research Areas:  

Neurological Disease

AN317 is a selective agonist for α6β2-containing nicotinic acetylcholine receptor (nAChR) with Ki of 6.2 nM and 4.1 nM, for α6/α3β2β3 receptor and α4β2 receptor, respectively. AN317 induces dopamine release in the synaptosomes of the rat striatum, enhances dopaminergic neuronal activity in substantia nigra, and exhibits protective efficacy to rat neurons against dopamine neurotoxin MPP +. AN317 exhibits good pharmacokinetic characteristics in rats. AN317 penetrates the blood-brain barrier (BB) .
loading...
    loading...
Cat. No.: HY-19411
CAS No.: 446031-79-4
Target:  

nAChR

Research Areas:  

Neurological Disease

SSR180711 hydrochloride is an orally active, selective and reversible α7 acetylcholine nicotinic receptor (n-AChRs) partial agonist. SSR180711 hydrochloride can act on rat α7 n-AChR (Ki=22 nM; IC50=30 nM) and human α7 n-AChR (Ki=14 nM; IC50=18 nM). SSR180711 hydrochloride increases glutamatergic neurotransmission, ACh release and long-term potentiation (LTP) in the hippocampus .
loading...
    loading...
Cat. No.: HY-P5833
CAS No.: 124511-67-7
Synonyms: κ-Bgt
Target:  

nAChR

Research Areas:  

Neurological Disease

κ-Bungarotoxin (κ-Bgt) is a potent, selective, and slowly reversible antagonist of α3β2 neuronal nicotinic acetylcholine receptors with an IC50 of 2.30 nM .
loading...
    loading...
Cat. No.: HY-114791
CAS No.: 552-72-7
Lobelanidine is an antagonist for nicotinic acetylcholine receptor (nAChR), which inhibits α7 nAChR response and α3β2/α3β4 nAChR responses, with IC50 of 2.8 and 8.2 μM .
loading...
    loading...
Cat. No.: HY-A0106R
CAS No.: 14769-73-4
Synonyms: (-)-Tetramisole (Standard)
Levamisole (Standard) is the analytical standard of Levamisole. This product is intended for research and analytical applications. Levamisole ((-)-Levamisole), an anthelmintic agent with immunomodulatory properties. Levamisole acts as a positive allosteric modulator (PAM) for the α3β2 (EC50=300 μM) and α3β4 (EC50=100 μM) subtype of nAChRs. Orally active .
loading...
    loading...
Cat. No.: HY-D1398
Target:  

nAChR

Research Areas:  

Neurological Disease

LtIA-F, a novel fluorescent analogue of LtIA, provides a wealth of pharmacological tools to explore the structure–function relationship, distribution, and ligand binding domain of the α3β2 nAChR subtype.
loading...
    loading...
Cat. No.: HY-110121R
CAS No.: 216853-60-0
Research Areas:  

Neurological Disease

NS3861 fumarate (Standard) is the analytical standard of NS3861 (fumarate) (HY-110121). This product is intended for research and analytical applications. NS3861 fumarate is an agonist of nicotinic acetylcholine receptors (nAChRs) and binds with high affinity to heteromeric α3β4 nAChR. The binding Ki values of 0.62, 25, 7.8, 55 nM for α3β4, α3β2, α4β4, α4β2, respectively .
loading...
    loading...
Cat. No.: HY-19438
CAS No.: 90808-12-1
Synonyms: RU 32698
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Divaplon is a GABA receptor agonist with the EC50 values of 31 and 2 nM for α3β2γ2 and α5β2γ2, respectively. Divaplon shows anxiolytic activity .
loading...
    loading...
Cat. No.: HY-117106
CAS No.: 200266-76-8
Target:  

GABA Receptor

Research Areas:  

Others

PNU-107484A is a GABAA receptor ligand that exhibits target activity mechanisms dependent on α isoforms. In the α1β2γ2 subtype, PNU-107484A acts as a positive allosteric modulator, enhancing GABA-induced Cl - currents, while it inhibits the currents in the α3β2γ2 and α6β2γ2 subtypes. The half-maximal concentrations for the α1β2γ2, α3β2γ2, and α6β2γ2 subtypes are 3.1, 4.2, and 3.5 μM, respectively. PNU-107484A can be used as a probe to investigate the physiological roles of different α isoform subtypes .
loading...
    loading...
Cat. No.: HY-129431
CAS No.: 157013-32-6
Synonyms: PNU-89843
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

U-89843A (PNU-89843) is a GABAA receptors positive allosteric modulator (PAM). U-89843A enhances GABA-induced Cl - currents in the α1β2γ2, α3β2γ2 and α6β2γ2 subtypes. U-89843A shows antioxidant and sedative effects .
loading...
    loading...
Cat. No.: HY-103497
CAS No.: 157013-85-9
Synonyms: PNU-89843 hydrochloride
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

U-89843A (PNU-89843) hydrochloride is a GABAA receptors positive allosteric modulator (PAM). U-89843A hydrochloride enhances GABA-induced Cl - currents in the α1β2γ2, α3β2γ2 and α6β2γ2 subtypes. U-89843A hydrochloride shows antioxidant and sedative effects .
loading...
    loading...
Cat. No.: HY-175251
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

GABAA receptor modulator-9 is and positive allosteric modulator of a1β2y2 subtype GABAA that can cross the blood-brain barrier. GABAA receptor modulator-9 exhibits comparable activity on α1β2γ2 (EC50: 0.9 μM in oocytes, 0.2 μM in CHO cells) and on α1β2, α3β2γ2 and α1β3γ2 (EC50s of 1.3, 3.4 and 1.1 μM). GABAA receptor modulator-9 significantly suppresses seizure progression and reduces delayed mortality. GABAA receptor modulator-9 can be used for the study of status epilepticus (SE) .
loading...
    loading...
Cat. No.: HY-185007
CAS No.: 1849624-82-3
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

LI-633 is a selective and orally active GABAA receptor positive allosteric modulator (PAM) with a Ki of 21 nM. LI-633 produces robust potentiation of GABA-induced inward current, with EC50 values ranging from 8 nM (α5β2γ2) to 128 nM (α3β2γ2). LI-633 potentiates muscimol-induced GABAergic currents in rat dorsal root ganglion (DRG) neurons with an EC50 of 70.4 nM. LI-633 can be used for the study of visceral pain .
loading...
    loading...
  • 1